Narcan is becoming harder to find at drugstores across America
The drug, also known as naloxone, reverses the effects of an opioid overdose
With the opioid crisis in the United States continuing to kill thousands of people every year, many are touting the benefits of a potentially life-saving drug: Narcan, which can prevent overdose deaths if administered quickly. But in recent months, getting your hands on a vial of Narcan has been easier said than done.
Narcan, also sold as the generic medication naloxone, can reverse the effects of opioid overdoses — including heroin, fentanyl and prescriptions — when given in time. It is sold as a two-pack of nasal spray, and unlike other overdose-reversing medications, has been approved for over-the-counter sales at drugstores. However, this also means that Narcan is susceptible to supply chain issues that can plague nationwide chains.
Narcan is already commonplace in medical settings. But anti-drug activists have long pushed for the medicine, and other versions of naloxone, to be more readily available in public places in the event of an overdose emergency. Why, then, is Narcan becoming more difficult to find, and how can its accessibility be improved?
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Why is Narcan so hard to find?
Part of the issue, experts say, is that the rollout has been problematic — and different at locations across the country. Some stores stock Narcan "on display on the pharmacy counter; in the pain medication aisle; behind the pharmacy counter; or behind the front register," NBC News said. Sometimes, the medicine was "easy to spot and access. Other times, a customer would have to hunt or ask for help."
NBC investigated the rollout in greater detail and found that Narcan was often kept in haphazard locations at these stores. At a CVS pharmacy near Pittsburgh, it was "spotted in a locked case on a shelf marked 'Covid tests,'" NBC said, while at a Publix pharmacy in Tennessee, it was "nearly obscured" by "pamphlets advertising 'Pet meds for less.'"
And these were just the pharmacies that had Narcan in stock. A recent Rice University study into the availability of naloxone near Houston found that "of the 156 pharmacies they contacted, 71% of the Houston pharmacies [still] kept it behind the pharmacist's counters or were entirely out of the product," the Texas Tribune said.
And for addicts that do not live near a drugstore, finding Narcan can be even more difficult, if not impossible. While most major drugstores carry the drug, "none of the convenience stores or gas stations" that NBC visited did, the outlet said. Not selling Narcan in gas stations and convenience stores, which are typically ubiquitous, is a "missed opportunity," Dr. Maryam Jowza, a chronic pain expert at the UNC School of Medicine in North Carolina, said to NBC. If someone "can buy kratom at a gas station, why not Narcan?" Jowza said, referring to a pain supplement sold in the U.S. despite being unregulated.
Even those who can find the drug might not be able to purchase it due to rising costs. At most retail stores, a "two-dose box of nasal naloxone can run $47 to $100," the Kansas City Beacon said, while name-brand Narcan "could cost as much as $146 for a two-pack." Some insurances cover the drug — but not all, the Beacon said, meaning that "even someone with health insurance might have a hard time affording" Narcan.
How is this affecting the battle against opioid abuse?
Even as the drug has been approved for over-the-counter sales, many in the medical field have expressed skepticism that Narcan would put a dent in the opioid crisis. The Narcan approval is "not by any means a game changer," said Shoshana Aronowitz, a nurse practitioner and professor at the University of Pennsylvania, per the Philadelphia Inquirer.
The approval is a "tiny, tiny baby step that does not deserve a round of applause," Aronowitz said. When it comes to buying Narcan over-the-counter, stigmas remain that could "especially deter people who use drugs," said Lewis Nelson, the chair of the Department of Emergency Medicine and director of the Division of Medical Toxicology at Rutgers University, per the Inquirer.
"For those who don't have substance use concerns, they might go in and just ask for the product and not be concerned about what the other person’s thinking," Nelson said. But for someone with an opioid addiction, that is a "mental state that’s very hard for most of us to put ourselves into if we don’t live the life of somebody with the stigma and the marginalization that is so associated with substance use."
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Justin Klawans has worked as a staff writer at The Week since 2022. He began his career covering local news before joining Newsweek as a breaking news reporter, where he wrote about politics, national and global affairs, business, crime, sports, film, television and other Hollywood news. Justin has also freelanced for outlets including Collider and United Press International.
-
The Nutcracker: English National Ballet's reboot restores 'festive sparkle'
The Week Recommends Long-overdue revamp of Tchaikovsky's ballet is 'fun, cohesive and astoundingly pretty'
By Irenie Forshaw, The Week UK Published
-
Congress reaches spending deal to avert shutdown
Speed Read The bill would fund the government through March 14, 2025
By Peter Weber, The Week US Published
-
Today's political cartoons - December 18, 2024
Cartoons Wednesday's cartoons - thoughts and prayers, pound of flesh, and more
By The Week US Published
-
The future of fluoridated water is up for debate
The Explainer The oral benefits are watery
By Devika Rao, The Week US Published
-
The hidden cost of lead exposure on American mental health
Under The Radar Millions of mental health diagnoses have been linked to childhood lead exposure in new study
By Theara Coleman, The Week US Published
-
Will the murder of a health insurance CEO cause an industry reckoning?
Today's Big Question UnitedHealthcare CEO Brian Thompson was shot and killed in what police believe was a targeted attack
By Justin Klawans, The Week US Published
-
Bird flu one mutuation from human threat, study finds
Speed Read A Scripps Research Institute study found one genetic tweak of the virus could enable its spread among people
By Peter Weber, The Week US Published
-
Polycystic ovary syndrome: what it is, how it's treated and why it's often misunderstood
The Explainer PCOS affects millions, but there is still no cure outside of treating symptoms separately
By Theara Coleman, The Week US Published
-
The growing list of conditions weight-loss drugs could help with
The Explainer Ozempic and similar drugs have been linked to possibly helping diseases beyond diabetes and obesity. Are they miracle drugs?
By Theara Coleman, The Week US Published
-
Dark chocolate tied to lower diabetes risk
Speed Read The findings were based on the diets of about 192,000 US adults over 34 years
By Peter Weber, The Week US Published
-
The great departure: Texas OB-GYNs are leaving the Lone Star State
Under the radar The state is suffering an exodus of health care professionals, creating more maternity care deserts
By Theara Coleman, The Week US Published